These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 25174885
1. [Pediatric multiple sclerosis: is it different from the adult form?]. Araqi-Houssaini A, Dany F, Sekkat Z, Camara NA, Hazim A, Midafi N, Elotmani H, El Moutawakil B, Rafai MA, Slassi I. Rev Neurol (Paris); 2014; 170(8-9):531-5. PubMed ID: 25174885 [Abstract] [Full Text] [Related]
2. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Sadeghi Bahmani D. J Clin Med; 2020 May 02; 9(5):. PubMed ID: 32370288 [Abstract] [Full Text] [Related]
7. Pediatric Multiple Sclerosis Severity Score in a large US cohort. Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, Rodriguez M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Hurtubise BF, Roalstad S, Rose J, Casper TC, Chitnis T, US Network of Pediatric MS Centers. Neurology; 2020 Sep 29; 95(13):e1844-e1853. PubMed ID: 32690790 [Abstract] [Full Text] [Related]
11. Epileptic seizures in early-onset multiple sclerosis. Etemadifar M, Abtahi SH, Tabrizi N. Arch Iran Med; 2012 Jun 29; 15(6):381-3. PubMed ID: 22642251 [Abstract] [Full Text] [Related]
12. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score. Guerrero AL, Laherrán E, Gutiérrez F, Martín-Polo J, Iglesias F, Alcázar C, Peralta J, Rostami P. Acta Neurol Scand; 2008 Jan 29; 117(1):21-5. PubMed ID: 17883422 [Abstract] [Full Text] [Related]
13. Does early-onset multiple sclerosis differ from adult-onset form in Iranian people. Ashtari F, Shaygannejad V, Farajzadegan Z, Amin A. J Res Med Sci; 2010 Mar 29; 15(2):94-9. PubMed ID: 21526065 [Abstract] [Full Text] [Related]
14. Multiple sclerosis: clinical characteristics and disability progression in Moroccan children. Ait Ben Haddou E, Alhyan M, Aasfara J, Regragui W, Ibrahimi A, Razine R, Abouqal R, Benomar A, Yahyaoui M. J Neurol Sci; 2014 Nov 15; 346(1-2):128-32. PubMed ID: 25216553 [Abstract] [Full Text] [Related]
18. Characterization of a late-onset multiple sclerosis Portuguese cohort. Moura J, Duarte S, Oliveira V, Pereira D, Costa D, Samões R, Sousa AP, Silva AM, Santos E. Mult Scler Relat Disord; 2023 Feb 15; 70():104506. PubMed ID: 36638770 [Abstract] [Full Text] [Related]
19. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course? Sidhom Y, Damak M, Riahi A, Hizem Y, Mrissa R, Mhiri C, Gouider R. J Neurol Sci; 2014 Aug 15; 343(1-2):110-4. PubMed ID: 24980939 [Abstract] [Full Text] [Related]
20. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis. Markianos M, Koutsis G, Evangelopoulos ME, Mandellos D, Karahalios G, Sfagos C. J Neurochem; 2009 Jan 15; 108(1):158-64. PubMed ID: 19014375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]